Clinical trial
Effect of Albendazole Dose on Clearance of Filarial Worms
NCT00339417 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00339417 |
|---|---|
| Title | Effect of Albendazole Dose on Clearance of Filarial Worms |
| Official title | Effect of Albendazole and Ivermectin Dose on Wuchereria Bancrofti Microfilarial Clearance in Mali: A Randomized, Open Label Study |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphatic Filariasis |
| Intervention type | Drug |
| Interventions | Albendazole, Ivermectin |
| Enrollment | 1,000 |
| Start date | Feb 22, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 17, 2011 |
| First posted | Jun 21, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | Mali |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: